Olympus Corp (STU:OLY1) Stock Price, Trades & News

Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.

Financial Strength

5/10

Name	Current	Vs Industry
Cash-To-Debt	0.9
Equity-to-Asset	0.53
Debt-to-Equity	0.3
Debt-to-EBITDA	1.76
Interest Coverage	10.84
Piotroski F-Score	6/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	3.03	Distress Grey Safe
Beneish M-Score	-2.38	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

8/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	9.3
	3-Year EBITDA Growth Rate	-8.9
	3-Year EPS without NRI Growth Rate	-17.4
	3-Year FCF Growth Rate	-9.5
	3-Year Book Growth Rate	13
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	24.83
	Future 3-5Y Total Revenue Growth Rate Estimate	4.58

Momentum Rank

4/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	59.12
	9-Day RSI	55.92
	14-Day RSI	54.19
	3-1 Month Momentum %	1.21
	6-1 Month Momentum %	-21.14
	12-1 Month Momentum %	-12.12

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	1.62
	Quick Ratio	1.14
	Cash Ratio	0.5
	Days Inventory	209.09
	Days Sales Outstanding	73.14
	Days Payable	64.17

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	1.69
	Dividend Payout Ratio	0.48
	3-Year Dividend Growth Rate	23.3
	Forward Dividend Yield %	1.7
	5-Year Yield-on-Cost %	2.49
	3-Year Average Share Buyback Ratio	4.2
	Shareholder Yield %	4.01

Profitability Rank

8/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	64.72
	Operating Margin %	9.98
	Net Margin %	6.75
	EBITDA Margin %	13.46
	FCF Margin %	1.47
	OCF Margin %	9.68
	ROE %	8.96
	ROA %	4.7
	ROIC %	6.41
	3-Year ROIIC %	-155.06
	ROC (Joel Greenblatt) %	25.62
	ROCE %	9.66
	Years of Profitability over Past 10-Year	10
	Moat Score	7
	Tariff Resilience Score	8

GF Value Rank

4/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	28.92
	Forward PE Ratio	19.55
	PE Ratio without NRI	28.92
	Shiller PE Ratio	23.71
	Price-to-Owner-Earnings	31.84
	PEG Ratio	6.73
	PS Ratio	1.96
	PB Ratio	2.4
	Price-to-Tangible-Book	3.78
	Price-to-Free-Cash-Flow	105.11
	Price-to-Operating-Cash-Flow	19.54
	EV-to-EBIT	18.45
	EV-to-Forward-EBIT	15.33
	EV-to-EBITDA	14.01
	EV-to-Forward-EBITDA	10.5
	EV-to-Revenue	1.89
	EV-to-Forward-Revenue	2.26
	EV-to-FCF	104.94
	Price-to-GF-Value	0.68
	Price-to-Projected-FCF	1.57
	Price-to-Median-PS-Value	0.7
	Price-to-Graham-Number	2.2
	Earnings Yield (Greenblatt) %	5.42
	FCF Yield %	0.96
	Forward Rate of Return (Yacktman) %	2.25

Financials (Next Earnings Date:2026-08-07)

Annual Quarterly TTM

STU:OLY1's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

Olympus Corp Executives

Details

GF Value™: €14.06

STU:OLY1

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 1 Severe warning sign with OLY1. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil €)	5,706.728
	EPS (TTM) (€)	0.344
	Beta	0.4622
	3-Year Sharpe Ratio	-0.58
	3-Year Sortino Ratio	-0.7
	Volatility %	29.14
	14-Day RSI	54.19
	14-Day ATR (€)	0.320075
	20-Day SMA (€)	9.2611
	12-1 Month Momentum %	-12.12
	52-Week Range (€)	7.004 - 11.71
	Shares Outstanding (Mil)	1,062.82

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	6
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Olympus Corp Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Olympus Corp Stock Events

Financials Calendars

Event	Date	Price (€)
Second quarter earnings conference call for 2027	2026-11-06	In 109 days
Second quarter earnings results for 2027	2026-11-06	In 109 days
First quarter earnings conference call for 2027	2026-08-07	In 18 days
First quarter earnings results for 2027	2026-08-07	In 18 days
General meeting for 2026	2026-06-25 10:00	9.01 (+1.40%)
Annual report for 2026	2026-06-18	8.70 (+1.02%)
Fourth quarter earnings conference call for 2026	2026-05-12	8.47 (+1.90%)
Fourth quarter earnings results for 2026	2026-05-12	8.47 (+1.90%)
JPY 30.000000 Cash Dividend	2026-03-30	7.94 (-2.22%)
Third quarter earnings conference call for 2026	2026-02-13	10.63 (-0.19%)

Show

Entries

Olympus Corp Frequently Asked Questions

What is Olympus Corp(STU:OLY1)'s stock price today?

The current price of STU:OLY1 is €9.56. The 52 week high of STU:OLY1 is €11.71 and 52 week low is €7.00.

When is next earnings date of Olympus Corp(STU:OLY1)?

The next earnings date of Olympus Corp(STU:OLY1) is 2026-08-07.

Does Olympus Corp(STU:OLY1) pay dividends? If so, how much?

The Dividend Yield % of Olympus Corp(STU:OLY1) is 1.69% (As of Today), Highest Dividend Payout Ratio of Olympus Corp(STU:OLY1) was 1.26. The lowest was 0.15. And the median was 0.22. The Forward Dividend Yield % of Olympus Corp(STU:OLY1) is 1.7%. For more information regarding to dividend, please check our Dividend Page.

Press Release

	Subject	Date
	EAGLE Trial Shows Olympus(R) CADDIE(TM) AI Solution Aids in the Detection of High-Risk and Hard-to-Detect Colorectal Lesions	2026-02-02
	Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership	2025-12-14
	Olympus Unveils Corporate Strategy	2025-11-07
	Olympus Introduces NBI+TXI(TM) Observation Mode to the EVIS X1(TM) Endoscopy System CV-1500 Video System Center	2025-10-29
	Olympus Launches New Surgical Energy Device for Hemostatic Cutting and Vessel Sealing	2025-10-21
	Olympus Launches SecureFlex, a Single-use Fine Needle Biopsy Device	2025-10-06
	Olympus Launches OLYSENSE CAD/AI in the US and Europe	2025-09-30
	Olympus Commits to Advancing Sustainable Packaging Enabled by DuPont(TM) Tyvek(R) with Renewable Attribution	2025-09-30
	Olympus Enters Strategic Partnership to Develop Endoluminal Gastrointestinal Robotics	2025-07-25
	Olympus Appoints New CEO	2025-04-25

10/Page

Articles on Olympus Corp

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.